Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee advances 340B reporting and fee framework amid debate over fees and rural impact
Summary
The committee reported out Engrossed Second Substitute Senate Bill 59‑81 after adopting a striking amendment establishing HCA filing fees and a 340B reporting account; multiple amendments to remove fees, require 90% of revenues for patient care, or limit contract pharmacies to rural areas failed amid debate over federal preemption, transparency and litigation risk.
The Health Care and Wellness committee on Feb. 25 advanced Engrossed Second Substitute Senate Bill 59‑81, a comprehensive package of reporting and fee provisions for the federal 340B drug pricing program, after adopting a striking amendment that sets HCA authority for fees, creates a dedicated 340B program reporting account, and requires certain aggregate reporting.
The striking amendment H3663.1 — described by Representative Tai — would require covered entities to report aggregate payments related to contract pharmacies, have…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
